Salvatore Mascia, Continuus Pharmaceuticals CEO
January 6, 2022 09:34 AM ESTUpdated 10:12 AM
Manufacturing

MIT spin­out Con­tin­u­us calls up­on Skan­s­ka to build MA site with fed­er­al de­fense mon­ey

Josh Sullivan

A spin­out from an MIT lab has land­ed a deal with a Swedish de­vel­op­ment group to build a $125 mil­lion man­u­fac­tur­ing fa­cil­i­ty in Woburn, MA …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Af­ter stock slides, Am­gen ad­dress­es bone den­si­ty talk on obe­si­ty drug

J&J takes 340B fight with fed­er­al gov­ern­ment to court

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

New can­cer class heats up as BioN­Tech buys out Chi­na part­ner and its PD-L1/VEGF drug

Adap­ti­m­mune's sec­ond T cell re­cep­tor cell ther­a­py for rare sar­co­mas pass­es piv­otal test

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times